Sign in

NCT07863180RecruitingPhase 1/2

Tributyrin for Progressive Supranuclear Palsy (PSP): Virtual Trial

Tributyrin for PSP: Phase 1b Virtual Trial - Feasibility Study

Source: ClinicalTrials.gov · Last updated 5 Nov 2026

Brief summary (registry, in English)

This research is studying a supplement called tributyrin in people with Progressive Supranuclear Palsy (PSP) to learn about its safety and tolerability as a potential treatment. The goal of this research study is to see if a similar supplementation regimen and virtual testing is feasible for people with PSP.

Status (registry)
Recruiting
Phase (registry)
Phase 1/2
Study type
Interventional
Enrollment
15 (estimated)
First submitted
1 Oct 2026
Start date
1 Oct 2026
Primary completion date
May 2027
Lead sponsor
Prabesh Kanel
NCT number
NCT07863180

What you commit to

  • Study type: Interventional · Phase 1/2
  • Planned participants: 15
  • From 1 Oct 2026 to the primary completion date, May 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Regular use of typical anti-cholinergic drugs.

Other illness

  • Recent history of significant, uncontrolled GI disease such as Gastroesophageal reflux disease, colorectal cancer.
  • Any other condition or criterion that, in the opinion of the investigators, would preclude safe and meaningful participation in the study.

Other

  • Significant metabolic or uncontrolled medical comorbidity.
  • Women of child-bearing potential, or who are pregnant and/or nursing.
  • Suicidal ideation, as indicated by a response of 2 or 3 on question 9 of the Beck Depression Inventory.

Who the study is looking for

  • Male or Female, age 45 years and over.
  • Diagnosis of PSP-Richardson syndrome (RS) based on Movement Disorder Society (MDS) Criteria, including
    • Vertical supranuclear gaze palsy.
    • Repeated unprovoked falls OR tendency to fall on the pull test within 3 years.
  • Access to the internet and webcam for virtual visits.
  • Presence of a caregiver.

Age in the registry: 45 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
Domino's Farms
Coordinator of this site? Confirm its status
Ann ArborUnited StatesRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.